THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION (STEMI)

ACE

Angiotensin Converting Enzyme

ACS

Acute Coronary Syndrome

AF

Atrial Fibrillation

AMI

Acute Myocardial Infarction

ARBS

Angiotensinogen Receptor Blockers

ARNI

Angiotensin Receptor/Neprilysin Inhibitor

AV BLOCK

Atrio Ventricular Block

b.i.d

Bid In Die (Twice Daily)

BP

Blood Pressure

C/I

Contraindicated

CABG

Coronary Artery Bypass Graft

CAD

Coronary Artery Disease

CCBs

Calcium Channel Blockers

CCU/ICU

Coronary Care Unit/ Intensive Care Unit

CMR

Cardiac Magnetic Resonance

CSK9i

Protein Convertase Subtilisin/Kexin Type 9

D2B

Door To Balloon

DAPT

Dual Antiplatelet Therapy

DES

Drug Eluting Stent

ECG

Electrocardiogram

ECLS

Extra Corporeal Life Support

ECMO

Extra Corporeal Membrane Oxygenator

eGFR

Estimated Glomerular Filtration Rate

EMS

Emergency Medical System

ER

Emergency Room

ESC

European Society of Cardiology

FMC

First Medical Contact

GP

Glycoprotein

GPI

Glycoprotein Inhibitor

HF

Heart Failure

hsTn

High Sensitivity Troponin

I.V.

Intra Venous

IABP

Intra-Aortic Balloon Pump

IC

Intra Coronary

ICCU

Intensive Coronary Care Unit

ICD

Internal Cardioverter Defibrillator

IRA

Infarct Related Artery

LBBB

Left Bundle Branch Block

LDL-C

Low Density Lipoprotein Cholesterol

LV

Left Ventricle

LVADs

Left Ventricular Assist Devices

LVEF

Left Ventricular Ejection Fraction

MI

Myocardial Infarction

MRA

Mineralocorticoid Receptor Antagonist

PCI

Percutaneous Coronary Intervention

PET

Positron Emission Tomography

RCTs

Randomized Controlled Trials

RV

Right Ventricular

SaO2

Saturation of arterial Oxygen

SBP

Systolic Blood Pressure

SGLT2

Sodium-Glucose Co-Transporter-2

SPECT

Single Positron Emission Computed Tomography

STEMI

ST-Elevation Myocardial Infarction

T2DM

Type 2 Diabetes Mellitus

TNK-tPA

Tenecteplase Tissue Plasminogen Activator

UFH

Unfractionated Heparin

VF

Ventricular Fibrillation

VT

Ventricular Tachycardia